Loading page...
Loading page...
This round is closed. The next round and similar open calls are listed below. Synced from the EU Funding & Tenders Portal on 9 November 2026.
This call is closed. These open or upcoming calls fund the closest work.
Projects the EU funded under this call, with the organisation that led each one.
PackAheadSustainable cellulose-based flexible packaging powered by artificial intelligence, machine learning and digital technologies
Led by Teknologian Tutkimuskeskus VTT Oy · Finland · 2026 · Official record ↗
BioValueAIBioValueAI: Digital Innovations for Circulair Bioeconomy
Led by Stichting Wageningen Research · Netherlands · 2026 · Official record ↗
Based on projects the EU funded on the same subject in this programme.
CirculH2Hydrogenases for Large Scale Deployment of H2 as a Circular Energy Carrier in Industrial Biotechnology Based on Enzymatic Catalysts
HORIZON-CL6-2023-CircBio-01-5 · 2024 · Official record ↗
DIVERSIFY4FutureDiversifying aquaculture for the future: inclusion of low-trophic species for sustainable, innovative, healthy and circular food systems
HORIZON-CL6-2025-02-FARM2FORK-10 · 2026 · Official record ↗
CASI-BIOCascading and Sustainable Innovation for the Bioeconomy
HORIZON-CL6-2025-03-GOVERNANCE-04 · 2026 · Official record ↗
SYMBIOShaping symbiosis in bio-based industrial ecosystems based on circular by-design supply chains
HORIZON-CL6-2023-CircBio-01-7 · 2024 · Official record ↗
Sustain-a-bitePROPELLING HEALTH AND SUSTAINABILITY THROUGH INNOVATIVE FOOD PRODUCTS AND PROCESSES
HORIZON-CL6-2024-FARM2FORK-01-2 · 2024 · Official record ↗
RISE4UKRAINERecovery and Innovation through Sustainable Ecosystems for Ukraine
HORIZON-CL6-2025-01-CIRCBIO-13 · 2026 · Official record ↗
VISIONAIRVirtual Integration for Sustainable and Innovative Observation of Urban Air Quality
HORIZON-CL6-2025-01-ZEROPOLLUTION-01 · 2026 · Official record ↗
ROBUSTOORobust industrial biocatalysts with peroxygenase, phenol-oxidase or furfuryl-oxidase activities from bacterial and fungal hosts
HORIZON-CL6-2023-CircBio-01-5 · 2024 · Official record ↗
Each one links to its EU funding record and the partners it works with: a starting list for building a consortium.
Successful proposals should contribute to a clean, competitive and circular economy and sustainable bioeconomy, through the integration of digital solutions/AI, enabling the deployment of innovative circular and climate-neutral bio-based materials, processes and value chains with higher resource efficiency.
Project results are expected to contribute to all of the following expected outcomes:
There is an unprecedented amount of data available in the bio-based sector today, among others, from the ever-growing ‘-omics’ technologies and integration of sensors and the Internet of Things (IoT) devices. Big data and analytics solutions allow bio-based actors, in particular, the bio-based industry, but also other R&I and civil society stakeholders, to tap into this wealth of data to drive innovation and sustainability. Operators already use the bioinformatics solutions but there is still much potential to explore undiscovered bio-based systems, improve processes and develop cleaner solutions (e.g. see parallel topics HORIZON-CL6-2025-01-CIRCBIO-14: Bioprospecting of marine natural products in the omics & artificial intelligence era, and HORIZON-CL6-2025-01-CIRCBIO-08: Bioprospecting and optimized production of the terrestrial natural products: new opportunities for bio-based sectors).
AI enables also the bio-based operators to automate a wide range of processes, helping them scale up their operations. Using AI image analysis or leveraging deep learning can be used to analyse microbiomes, screen phenotypes, and develop rapid diagnostics in a vast range of applications. Use of AI to predict best metabolic pathways for biosynthesis, optimize/engineer enzymatic activities, and virtually test several variables can speed up bioprocesses’ development, while helping to reduce costs and deliver novel molecules for the market. Also, streamlining biorefineries with AI can led to several levels of productivity gains. Moreover, systemic and integrated modelling approaches can optimise the rational deployment of bio-based value chains.
The action will first, explore the potential of AI and other digital technologies and tools in the bio-based sector and, next, focus on developing new capacities, high-quality tools and algorithms of AI and other digital technologies and tools to be demonstrated for the most promising (in terms of impact on environmental sustainability and competitiveness) applications of this sector. In this context, the concept of a ‘digital twin’[1] could be explored. Generative artificial intelligence is in scope, if relevant to the proposed concept.
In line with the current definition of the EU bioeconomy strategy, health biotechnology sector is not in scope.
The scope covers all relevant aspects of the contribution of AI/digital methodologies and tools capable of delivering the high sustainability gains (resource efficiency, circularity, climate neutrality etc), as well as enhance the European industrial competitiveness (in particular in regard to improved quality of bio-based products, strategic autonomy, resilience and role of innovative SMEs). The proposals should demonstrate the upscaling from the current potential, align it to parallel actions on AI and other digital technologies and tools (e.g. database development, predictive capacities, EU-level initiatives (e.g. EU AI Act, Biotechnology and Biomanufacturing Initiative), and incorporate the systematic assessment of the risks and opportunities for the sector.
Multi-actor Approach (MAA) and social innovation are encouraged, especially to address the societal concerns and perceptions on the role of AI in the bio-based innovation and broader bioeconomy (e.g., impacts on skills and job opportunities/risks). All relevant stakeholders and value chain actors are in scope. Links to the Circular Bio-based Europe Joint Undertaking (CBE JU) operations are strongly encouraged. Proposals should also consider citizens engagement and dialogue, for seeking wider input and support, and encourage social innovation approaches.
Proposals should take into account the findings of the Global Resources Outlook 2024 of the International Resource Panel. Any risks to the ecosystems should be assessed and minimised, along the application of the Do-No-Significant-Harm (DNSH) principle.
The action will serve to develop guidelines for the policy makers, industry and civil society, in an inclusive co-creation process.
Proposals should include a task dedicated to sharing methodologies and findings with projects funded under this topic and with similar recent or ongoing projects.
Proposals should leverage the data and services available through European Research Infrastructures federated under the European Open Science Cloud, as well as data from relevant Data Spaces. Proposals are encouraged to consider, where relevant, the services offered by European research infrastructures such as IBISBA or other relevant research infrastructures[2].
International cooperation is encouraged, e.g. with countries mentioned in the EU biotechnology and biomanufacturing initiative communication, such as United States of America, Japan, South Korea, and India, for win-win outcomes and mutual benefits.
null
Activities are expected to achieve TRL 7 by the end of the project – see General Annex B. Activities may start at any TRL.
[1] A digital twin is a digital representation of a physical object, person, or process, contextualized in a digital version of its environment. Digital twins can help an organization simulate real situations and their outcomes, ultimately allowing it to make better decisions.
[2] The catalogue of European Strategy Forum on Research Infrastructures (ESFRI) research infrastructures portfolio can be browsed from ESFRI website https://ri-portfolio.esfri.eu/
1. Admissibility Conditions: Proposal page limit and layout
described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible Countries
described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other Eligible Conditions
described in Annex B of the Work Programme General Annexes.
4. Financial and operational capacity and exclusion
described in Annex C of the Work Programme General Annexes.
5a. Evaluation and award: Award criteria, scoring and thresholds
are described in Annex D of the Work Programme General Annexes.
5b. Evaluation and award: Submission and evaluation processes
are described in Annex F of the Work Programme General Annexes and the Online Manual.
5c. Evaluation and award: Indicative timeline for evaluation and grant agreement
described in Annex F of the Work Programme General Annexes.
6. Legal and financial set-up of the grants
described in Annex G of the Work Programme General Annexes.
described in the [specific topic of the Work Programme]
Application and evaluation forms and model grant agreement (MGA):
Application form templates — the application form specific to this call is available in the Submission System
Standard application form (HE RIA, IA)
Evaluation form templates — will be used with the necessary adaptations
Standard evaluation form (HE RIA, IA) 
Guidance
HE Programme Guide 
Model Grant Agreements (MGA)
HE MGA 
Call-specific instructions 
Additional documents:
HE Main Work Programme 2025 – 1. General Introduction
HE Main Work Programme 2025 – 9. Food, Bioeconomy, Natural Resources, Agriculture and Environment
HE Main Work Programme 2025 – 14. General Annexes
HE Programme Guide
HE Framework Programme 2021/695
HE Specific Programme Decision 2021/764 
EU Financial Regulation 2024/2509
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment 
EU Grants AGA — Annotated Model Grant Agreement 
Funding & Tenders Portal Online Manual 
Funding & Tenders Portal Terms and Conditions 
Funding & Tenders Portal Privacy Statement
Applicants asked the EU 1 questions about this call and the EU published the answers. They clarify the call documents but do not replace them.
As per the text describing the two topics, "HORIZON-CL6-2025-01-CIRCBIO-09: Bioprospecting and optimized production of the terrestrial natural products: new opportunities for bio-based sectors" and "HORIZON-CL6-2025-01-CIRCBIO-14 - Bioprospecting of marine natural products in the omics and artificial intelligence era", clinical trials are not a requested element and therefore should not be part of the proposal. What is indeed requested is that safety to the end-users and operators needs to be assessed and guaranteed. The required clinical trials for developing pharmaceuticals or their ingredients, should be planned outside of the project with other source of funding (for e.g. from Horizon Europe Health Cluster).
Read it on the EU portal ↗Answered 15 Jun 2025
Confirm the current call documents and submission conditions with the funding authority.
View on EU portal ↗Source: EU Funding & Tenders Portal · synced 2026-11-09
A free account keeps your shortlist and sends deadline reminders. The EUACC connector brings this call, its FAQs, past winners and similar calls into Claude or ChatGPT, so you can check fit and draft with sources.